Benzinga | May 6, 2021 08:42AM EDT

Aditxt Signs Channel Partner Agreement with Meridian HSN to Make AditxtScore for COVID-19 Available to its Network of Healthcare Provider Partners

Aditx Therapeutics, Inc. (Aditxt) (the "Company") (NASDAQ:ADTX), a biotech innovation company focused on improving the health of the immune system, today announced that Meridian Health Services Network (Meridian HSN) will offer AditxtScore(tm) for COVID-19 to its network of healthcare provider partners.

Aditxt is pioneering the development of a new technology platform that provides a personalized, comprehensive profile of the immune system. By assessing an individual's immune biomarkers, AditxtScore will be able to measure indications of immunity to specific disease. AditxtScore applications include the recently commercialized AditxtScore for COVID-19, developed for use in detecting antibodies and neutralizing antibodies against SARS-CoV-2 antigens. Other applications under development include, among others, predicting dynamic monitoring of the immune system in infectious and autoimmune diseases, organ transplantation, gut health, and allergy.